Hot Features
プレミアム
Hims and Hers Health Inc (HIMS)
NYSE
登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-06-15 | Dr. Patrick CarrollChief Medical Officer | -8.31k | 250.71k | Derivative Exercise and Sale | 30.17 | 205.59k | - |
| 2026-06-15 | Ms. Soleil Teubner BoughtonChief Legal Officer & Corporate Secretary | 18.95k | 0.00 | Derivative Exercise and Retained Stock | - | 318.31k | 6.33% |
| 2026-06-15 | Ms. Soleil Teubner BoughtonChief Legal Officer & Corporate Secretary | -23.32k | 703.41k | Derivative Exercise and Sale | 30.17 | 318.31k | - |
| 2026-06-15 | Ms. Irene A. BecklundSenior VP, Controller & Principal Accounting Officer | -15.97k | 485.81k | Derivative Exercise and Sale | 30.17 - 31.50 | 6.79k | - |
| 2026-06-17 | Ms. Irene A. BecklundSenior VP, Controller & Principal Accounting Officer | -1.96k | 61.80k | Automatic Disposition | 31.50 | 6.79k | -22.42% |
| 2026-06-15 | Ms. Deborah M. AutorChief Policy Officer & Director | 17.52k | 0.00 | Derivative Exercise and Retained Stock | - | 48.96k | 55.74% |
| 2026-06-15 | Ms. Deborah M. AutorChief Policy Officer & Director | -15.40k | 464.50k | Derivative Exercise and Sale | 30.17 | 48.96k | - |
| 2026-06-15 | Dr. Patrick CarrollChief Medical Officer | 17.62k | 0.00 | Derivative Exercise and Retained Stock | - | 205.59k | 9.37% |
| 2026-06-15 | Mr. Mohamed ElShenawyCTO | 101.02k | 0.00 | Derivative Exercise and Retained Stock | - | 101.02k | - |
| 2026-06-15 | Mr. Mohamed ElShenawyCTO | -181.57k | 5.52M | Derivative Exercise and Sale | 30.17 - 31.50 | 101.02k | - |
| 2026-06-11 | Ms. Andrea G. Perez GarciaIndependent Director | 3.66k | 0.00 | Derivative Exercise and Retained Stock | - | 83.82k | 4.56% |
| 2026-06-11 | Mr. Kare SchultzIndependent Director | 3.66k | 0.00 | Derivative Exercise and Retained Stock | - | 19.40k | 23.23% |
| 2026-06-11 | Mr. David B. WellsLead Independent Director | 4.61k | 0.00 | Derivative Exercise and Retained Stock | - | 229.03k | 2.06% |
| 2026-06-11 | Dr. Delos M. CosgroveIndependent Director | 3.66k | 0.00 | Derivative Exercise and Retained Stock | - | 68.00k | 5.68% |
| 2026-06-11 | Ms. Anja Lucia ManuelIndependent Director | 13.70k | 0.00 | Derivative Exercise and Retained Stock | - | 38.67k | 54.84% |
| 2026-06-11 | Ms. Christiane Pendarvisインサイダー | 3.66k | 0.00 | Derivative Exercise and Retained Stock | - | 55.43k | 7.06% |
| 2026-06-11 | Mr. Christopher D. PayneIndependent Director | 14.34k | 0.00 | Derivative Exercise and Retained Stock | - | 144.32k | 11.04% |
| 2026-06-11 | Ms. Deborah M. AutorChief Policy Officer & Director | 3.66k | 0.00 | Derivative Exercise and Retained Stock | - | 31.44k | 13.16% |
| 2026-06-11 | Dr. Patrick CarrollChief Medical Officer | 4.09k | 0.00 | Derivative Exercise and Retained Stock | - | 187.97k | 2.22% |
| 2026-05-26 | Mr. David B. WellsLead Independent Director | 48.40k | 1.17M | 買い | 24.24 | 224.42k | 27.50% |
| 2026-05-18 | Mr. Oluyemi OkupeCFO | -7.95k | 148.09k | Derivative Exercise and Sale | 5.01 - 23.64 | 270.81k | - |
| 2026-04-20 | Mr. Oluyemi OkupeCFO | -12.55k | 267.59k | Derivative Exercise and Sale | 5.01 - 29.96 | 270.81k | - |
| 2026-04-20 | Mr. Oluyemi OkupeCFO | -7.09k | 212.49k | Automatic Disposition | 29.96 | 270.81k | -2.55% |
| 2026-04-20 | Ms. Soleil Teubner BoughtonChief Legal Officer & Corporate Secretary | -9.46k | 283.89k | Automatic Disposition | 30.00 | 299.37k | -3.06% |
| 2026-04-17 | Mr. Oluyemi OkupeCFO | -6.18k | 141.15k | Derivative Exercise and Sale | 5.01 - 27.83 | 277.90k | - |
| 2026-04-16 | Mr. Oluyemi OkupeCFO | -48.74k | 1.29M | Automatic Disposition | 25.90 - 27.83 | 277.90k | -14.92% |
| 2026-04-09 | Mr. Andrew DudumCo-Founder, Chairman & CEO | -422.93k | 0.00 | Other Disposition | - | 9.53M | -4.25% |
| 2026-04-06 | Mr. Oluyemi OkupeCFO | -3.98k | 59.49k | Derivative Exercise and Sale | 5.01 - 19.98 | 326.64k | - |
| 2026-03-20 | Mr. Oluyemi OkupeCFO | -4.49k | 84.20k | Derivative Exercise and Sale | 5.01 - 23.77 | 326.64k | - |
| 2026-03-20 | Mr. Oluyemi OkupeCFO | -4.73k | 112.37k | Automatic Disposition | 23.77 | 326.64k | -1.43% |
| 2026-03-17 | Mr. Mike ChiCOO | -97.29k | 2.40M | Automatic Disposition | 24.69 | 407.28k | -19.28% |
| 2026-03-17 | Ms. Soleil Teubner BoughtonChief Legal Officer & Corporate Secretary | -4.81k | 118.81k | Automatic Disposition | 24.69 | 308.83k | -1.53% |
| 2026-03-17 | Ms. Irene A. BecklundSenior VP, Controller & Principal Accounting Officer | -5.53k | 136.51k | Automatic Disposition | 24.69 | 8.75k | -38.72% |
| 2026-03-13 | Mr. Mike ChiCOO | 32.89k | 0.00 | Derivative Exercise and Retained Stock | - | 504.57k | 6.97% |
| 2026-03-13 | Mr. Mike ChiCOO | -39.21k | 971.33k | Derivative Exercise and Sale | 24.77 | 504.57k | - |
| 2026-03-13 | Mr. Mike ChiCOO | -198.54k | 4.92M | Sale to Issuer | 24.77 | 504.57k | -28.24% |
| 2026-03-13 | Ms. Christiane Pendarvisインサイダー | 15.21k | 0.00 | Derivative Exercise and Retained Stock | - | 51.77k | 41.60% |
| 2026-03-13 | Ms. Soleil Teubner BoughtonChief Legal Officer & Corporate Secretary | 19.25k | 0.00 | Derivative Exercise and Retained Stock | - | 313.64k | 6.54% |
| 2026-03-13 | Ms. Soleil Teubner BoughtonChief Legal Officer & Corporate Secretary | -22.17k | 549.23k | Derivative Exercise and Sale | 24.77 | 313.64k | - |
| 2026-03-13 | Ms. Soleil Teubner BoughtonChief Legal Officer & Corporate Secretary | -146.58k | 3.63M | Sale to Issuer | 24.77 | 313.64k | -31.85% |
| 2026-03-13 | Ms. Irene A. BecklundSenior VP, Controller & Principal Accounting Officer | 12.16k | 0.00 | Derivative Exercise and Retained Stock | - | 14.28k | 571.73% |
| 2026-03-13 | Ms. Irene A. BecklundSenior VP, Controller & Principal Accounting Officer | -5.83k | 144.46k | Derivative Exercise and Sale | 24.77 | 14.28k | - |
| 2026-03-13 | Ms. Deborah M. AutorChief Policy Officer & Director | 21.61k | 0.00 | Derivative Exercise and Retained Stock | - | 27.78k | 349.91% |
| 2026-03-13 | Ms. Deborah M. AutorChief Policy Officer & Director | -11.31k | 280.20k | Derivative Exercise and Sale | 24.77 | 27.78k | - |
| 2026-03-13 | Dr. Patrick CarrollChief Medical Officer | 12.50k | 0.00 | Derivative Exercise and Retained Stock | - | 182.44k | 7.36% |
| 2026-03-13 | Dr. Patrick CarrollChief Medical Officer | -4.02k | 99.62k | Derivative Exercise and Sale | 24.77 | 182.44k | - |
| 2026-03-13 | Mr. Oluyemi OkupeCFO | 47.29k | 0.00 | Derivative Exercise and Retained Stock | - | 331.37k | 16.65% |
| 2026-03-13 | Mr. Oluyemi OkupeCFO | -57.91k | 1.43M | Derivative Exercise and Sale | 24.77 | 331.37k | - |
| 2026-03-13 | Mr. Oluyemi OkupeCFO | -226.08k | 5.60M | Sale to Issuer | 24.77 | 331.37k | -40.56% |
| 2026-03-13 | Mr. Andrew DudumCo-Founder, Chairman & CEO | 74.07k | 0.00 | Derivative Exercise and Retained Stock | - | 9.53M | 0.78% |
| 2026-03-13 | Mr. Andrew DudumCo-Founder, Chairman & CEO | -90.30k | 2.24M | Derivative Exercise and Sale | 24.77 | 9.53M | - |
| 2026-03-13 | Mr. Andrew DudumCo-Founder, Chairman & CEO | -436.19k | 10.80M | Sale to Issuer | 24.77 | 9.53M | -4.38% |
| 2026-02-27 | Ms. Soleil Teubner BoughtonChief Legal Officer & Corporate Secretary | -4.65k | 70.74k | Automatic Disposition | 15.21 | 167.18k | -2.71% |
| 2026-02-03 | Mr. Oluyemi OkupeCFO | -5.26k | 112.75k | Derivative Exercise and Sale | 5.01 - 26.44 | 99.47k | - |
| 2026-01-20 | Mr. Oluyemi OkupeCFO | -9.07k | 218.28k | Derivative Exercise and Sale | 5.01 - 30.34 | 99.47k | - |
| 2026-01-05 | Mr. Oluyemi OkupeCFO | -5.99k | 147.43k | Derivative Exercise and Sale | 5.01 - 33.79 | 99.47k | - |
| 2026-01-05 | Mr. Oluyemi OkupeCFO | -3.08k | 104.20k | Automatic Disposition | 33.79 | 99.47k | -3.01% |
| 2025-12-22 | Mr. Oluyemi OkupeCFO | -23.09k | 824.71k | Automatic Disposition | 35.72 | 102.19k | -18.43% |
| 2025-12-17 | Dr. Patrick CarrollChief Medical Officer | -10.02k | 367.87k | Automatic Disposition | 36.71 | 169.94k | -5.57% |
| 2025-12-17 | Ms. Irene A. BecklundSenior VP, Controller & Principal Accounting Officer | -8.41k | 308.77k | Automatic Disposition | 36.71 | 2.13k | -79.82% |
| 2025-12-17 | Ms. Deborah M. AutorChief Policy Officer & Director | -7.05k | 258.95k | Automatic Disposition | 36.71 | 6.18k | -53.32% |
| 2025-12-17 | Mr. Mike ChiCOO | -13.75k | 504.76k | Automatic Disposition | 36.71 | 305.16k | -4.31% |
| 2025-12-15 | Ms. Soleil Teubner BoughtonChief Legal Officer & Corporate Secretary | 18.60k | 0.00 | Derivative Exercise and Retained Stock | - | 171.83k | 12.14% |
| 2025-12-15 | Ms. Soleil Teubner BoughtonChief Legal Officer & Corporate Secretary | -22.82k | 827.12k | Derivative Exercise and Sale | 36.25 | 171.83k | - |
| 2025-12-15 | Dr. Patrick CarrollChief Medical Officer | 10.02k | 0.00 | Derivative Exercise and Retained Stock | - | 179.96k | 5.90% |
| 2025-12-15 | Dr. Patrick CarrollChief Medical Officer | -6.50k | 235.63k | Derivative Exercise and Sale | 36.25 | 179.96k | - |
| 2025-12-15 | Ms. Deborah M. AutorChief Policy Officer & Director | 7.05k | 0.00 | Derivative Exercise and Retained Stock | - | 13.23k | 114.23% |
| 2025-12-15 | Mr. Mike ChiCOO | 32.24k | 0.00 | Derivative Exercise and Retained Stock | - | 318.91k | 11.24% |
| 2025-12-15 | Mr. Mike ChiCOO | -39.87k | 1.45M | Derivative Exercise and Sale | 36.25 | 318.91k | - |
| 2025-12-15 | Ms. Irene A. BecklundSenior VP, Controller & Principal Accounting Officer | 9.12k | 0.00 | Derivative Exercise and Retained Stock | - | 10.54k | 643.09% |
| 2025-12-15 | Ms. Irene A. BecklundSenior VP, Controller & Principal Accounting Officer | -8.87k | 321.43k | Derivative Exercise and Sale | 36.25 | 10.54k | - |
| 2025-12-15 | Mr. Oluyemi OkupeCFO | 47.19k | 0.00 | Derivative Exercise and Retained Stock | - | 125.28k | 60.44% |
| 2025-12-15 | Mr. Oluyemi OkupeCFO | -58.01k | 2.10M | Derivative Exercise and Sale | 36.25 | 125.28k | - |
| 2025-12-15 | Mr. Andrew DudumCo-Founder, Chairman & CEO | 73.71k | 0.00 | Derivative Exercise and Retained Stock | - | 9.10M | 0.82% |
| 2025-12-15 | Mr. Andrew DudumCo-Founder, Chairman & CEO | -90.66k | 3.29M | Derivative Exercise and Sale | 36.25 | 9.10M | - |
| 2025-12-09 | Ms. Andrea G. Perez GarciaIndependent Director | -2.50k | 97.93k | 売り | 39.17 | 80.17k | -3.02% |
| 2025-11-28 | Mr. Andrew DudumCo-Founder, Chairman & CEO | -1.08M | 0.00 | Other Disposition | - | 9.02M | -10.68% |
| 2025-12-01 | Mr. Mike ChiCOO | -5.00k | 0.00 | Other Disposition | - | 286.68k | -1.71% |
| 2025-11-24 | Ms. Soleil Teubner BoughtonChief Legal Officer & Corporate Secretary | -2.63k | 92.66k | Automatic Disposition | 35.22 | 153.23k | -1.69% |
| 2025-11-17 | Mr. Oluyemi OkupeCFO | -23.19k | 687.67k | Derivative Exercise and Sale | 5.01 - 36.81 | 78.09k | - |
| 2025-11-10 | Ms. Soleil Teubner BoughtonChief Legal Officer & Corporate Secretary | -2.64k | 112.15k | Automatic Disposition | 42.53 | 155.86k | -1.66% |
| 2025-11-07 | Mr. Andrew DudumCo-Founder, Chairman & CEO | -3.53M | 0.00 | Other Disposition | - | 9.02M | -28.10% |
| 2025-10-27 | Ms. Soleil Teubner BoughtonChief Legal Officer & Corporate Secretary | -2.64k | 132.11k | Automatic Disposition | 50.10 | 158.49k | -1.64% |
| 2025-10-17 | Mr. Oluyemi OkupeCFO | -11.59k | 579.32k | Derivative Exercise and Sale | 5.01 - 57.13 | 70.23k | - |
| 2025-10-16 | Mr. Andrew DudumCo-Founder, Chairman & CEO | -125.34k | 7.56M | Derivative Exercise and Sale | 2.43 - 63.49 | 9.28M | - |
| 2025-10-16 | Mr. Andrew DudumCo-Founder, Chairman & CEO | -50.33k | 3.16M | Automatic Disposition | 62.65 - 63.46 | 9.28M | -0.54% |
| 2025-10-13 | Ms. Soleil Teubner BoughtonChief Legal Officer & Corporate Secretary | -2.64k | 143.40k | Automatic Disposition | 54.38 | 161.13k | -1.61% |
| 2025-10-10 | Mr. Mike ChiCOO | -900.00 | 46.29k | Derivative Exercise and Sale | 6.82 - 58.25 | 291.44k | - |
| 2025-10-03 | Mr. Oluyemi OkupeCFO | -11.60k | 586.31k | Derivative Exercise and Sale | 5.01 - 57.72 | 78.09k | - |
| 2025-10-01 | Mr. Mike ChiCOO | -250.00 | 11.12k | Derivative Exercise and Sale | 11.53 - 56.00 | 291.44k | - |
| 2025-09-29 | Ms. Soleil Teubner BoughtonChief Legal Officer & Corporate Secretary | -2.64k | 155.03k | Automatic Disposition | 58.79 | 163.77k | -1.58% |
| 2025-09-29 | Mr. Oluyemi OkupeCFO | -49.83k | 2.75M | Derivative Exercise and Sale | 5.01 - 60.20 | 78.09k | - |
| 2025-09-29 | Mr. Oluyemi OkupeCFO | -35.17k | 2.12M | Automatic Disposition | 60.20 | 78.09k | -31.05% |
| 2025-09-24 | Mr. Mike ChiCOO | -2.10k | 108.17k | Derivative Exercise and Sale | 5.01 - 56.52 | 291.44k | - |
| 2025-03-07 | Mr. Mike ChiCOO | -5.70k | 0.00 | Other Disposition | - | 291.44k | -1.92% |
| 2025-09-22 | Mr. Oluyemi OkupeCFO | -23.58k | 1.36M | Automatic Disposition | 57.74 | 113.25k | -17.24% |
| 2025-09-17 | Mr. Mike ChiCOO | -13.75k | 694.32k | Automatic Disposition | 50.50 | 297.14k | -4.42% |
| 2025-09-17 | Dr. Patrick CarrollChief Medical Officer | -10.02k | 506.06k | Automatic Disposition | 50.50 | 169.94k | -5.57% |
| 2025-09-17 | Ms. Irene A. BecklundSenior VP, Controller & Principal Accounting Officer | -8.41k | 424.71k | Automatic Disposition | 50.50 | 1.42k | -85.57% |
| 2025-09-17 | Ms. Soleil Teubner BoughtonChief Legal Officer & Corporate Secretary | -2.64k | 133.17k | Automatic Disposition | 50.50 | 166.40k | -1.56% |
| 2025-09-17 | Mr. Andrew DudumCo-Founder, Chairman & CEO | -65.11k | 3.29M | Automatic Disposition | 50.57 | 9.33M | -0.69% |
| 2025-09-15 | Mr. Kare SchultzIndependent Director | 6.62k | 0.00 | Derivative Exercise and Retained Stock | - | 15.74k | 72.64% |
| 2025-09-15 | Mr. Mike ChiCOO | 72.11k | 0.00 | Derivative Exercise and Retained Stock | - | 310.89k | 30.20% |
| 2025-09-15 | Mr. Mike ChiCOO | -4.15k | 206.72k | Derivative Exercise and Sale | 5.01 - 56.00 | 310.89k | - |
| 2025-09-15 | Mr. Mike ChiCOO | -39.87k | 2.15M | Sale to Issuer | 53.96 | 310.89k | -11.37% |
| 2025-09-15 | Ms. Irene A. BecklundSenior VP, Controller & Principal Accounting Officer | 9.12k | 0.00 | Derivative Exercise and Retained Stock | - | 9.83k | 1,280.34% |
| 2025-09-15 | Ms. Irene A. BecklundSenior VP, Controller & Principal Accounting Officer | -8.87k | 478.46k | Derivative Exercise and Sale | 53.96 | 9.83k | - |
| 2025-09-15 | Ms. Soleil Teubner BoughtonChief Legal Officer & Corporate Secretary | 18.59k | 0.00 | Derivative Exercise and Retained Stock | - | 169.04k | 12.36% |
| 2025-09-15 | Ms. Soleil Teubner BoughtonChief Legal Officer & Corporate Secretary | -22.83k | 1.23M | Derivative Exercise and Sale | 53.96 | 169.04k | - |
| 2025-09-15 | Mr. Oluyemi OkupeCFO | 105.20k | 0.00 | Derivative Exercise and Retained Stock | - | 136.84k | 332.51% |
| 2025-09-15 | Mr. Oluyemi OkupeCFO | -110.00k | 5.53M | Derivative Exercise and Sale | 5.01 - 55.25 | 136.84k | - |
| 2025-09-15 | Mr. Oluyemi OkupeCFO | -35.00k | 1.95M | Automatic Disposition | 55.25 - 55.79 | 136.84k | -20.37% |
| 2025-09-15 | Mr. Oluyemi OkupeCFO | -58.02k | 3.13M | Sale to Issuer | 53.96 | 136.84k | -29.78% |
| 2025-09-15 | Dr. Patrick CarrollChief Medical Officer | 10.02k | 0.00 | Derivative Exercise and Retained Stock | - | 179.96k | 5.90% |
| 2025-09-15 | Dr. Patrick CarrollChief Medical Officer | -6.50k | 350.74k | Derivative Exercise and Sale | 53.96 | 179.96k | - |
| 2025-09-15 | Mr. Andrew DudumCo-Founder, Chairman & CEO | 164.37k | 0.00 | Derivative Exercise and Retained Stock | - | 9.40M | 1.78% |
| 2025-09-15 | Mr. Andrew DudumCo-Founder, Chairman & CEO | -90.67k | 4.89M | Sale to Issuer | 53.96 | 9.40M | -0.96% |
| 2025-09-16 | Mr. Andrew DudumCo-Founder, Chairman & CEO | -50.33k | 2.68M | Automatic Disposition | 52.90 - 54.21 | 9.40M | -0.53% |
| 2025-09-16 | Mr. Andrew DudumCo-Founder, Chairman & CEO | -125.34k | 6.40M | Derivative Exercise and Sale | 2.43 - 53.81 | 9.40M | - |
| 2025-08-26 | Mr. Oluyemi OkupeCFO | -11.58k | 447.95k | Derivative Exercise and Sale | 5.01 - 43.69 | 124.66k | - |
| 2025-08-25 | Ms. Soleil Teubner BoughtonChief Legal Officer & Corporate Secretary | -2.57k | 114.49k | 売り | 44.53 | 150.45k | -1.68% |
| 2025-08-18 | Mr. Andrew DudumCo-Founder, Chairman & CEO | -125.34k | 5.34M | Derivative Exercise and Sale | 2.43 - 45.14 | 9.38M | - |
| 2025-08-18 | Mr. Andrew DudumCo-Founder, Chairman & CEO | -50.33k | 2.27M | Automatic Disposition | 44.97 - 45.05 | 9.38M | -0.53% |
| 2025-08-13 | Mr. Oluyemi OkupeCFO | -11.58k | 498.40k | Derivative Exercise and Sale | 5.01 - 48.05 | 124.66k | - |
| 2025-08-11 | Ms. Soleil Teubner BoughtonChief Legal Officer & Corporate Secretary | -2.57k | 132.82k | 売り | 51.64 | 153.02k | -1.65% |
| 2025-08-07 | Mr. Andrew DudumCo-Founder, Chairman & CEO | -660.00k | 33.38M | 売り | 50.58 | 9.43M | -6.54% |
| 2025-08-06 | Dr. Patrick CarrollChief Medical Officer | -60.00k | 3.21M | 売り | 53.58 | 169.94k | -26.09% |
| 2025-07-31 | Mr. Mike ChiCOO | -26.60k | 1.59M | Derivative Exercise and Sale | 5.01 - 67.00 | 278.65k | - |
| 2025-07-28 | Ms. Soleil Teubner BoughtonChief Legal Officer & Corporate Secretary | -2.57k | 150.98k | Automatic Disposition | 58.70 | 155.59k | -1.63% |
| 2025-07-23 | Mr. Mike ChiCOO | -15.85k | 808.12k | Derivative Exercise and Sale | 5.01 - 57.52 | 278.65k | - |
| 2025-07-21 | Mr. Andrew DudumCo-Founder, Chairman & CEO | -125.34k | 5.90M | Derivative Exercise and Sale | 2.43 - 49.60 | 10.09M | - |
| 2025-07-16 | Mr. Andrew DudumCo-Founder, Chairman & CEO | -50.33k | 2.53M | Automatic Disposition | 50.24 - 50.82 | 10.09M | -0.50% |
| 2025-07-14 | Ms. Soleil Teubner BoughtonChief Legal Officer & Corporate Secretary | -2.57k | 122.99k | Automatic Disposition | 47.82 | 158.17k | -1.60% |
| 2025-07-14 | Mr. Oluyemi OkupeCFO | -7.59k | 323.89k | Derivative Exercise and Sale | 5.01 - 47.70 | 124.66k | - |
| 2025-07-14 | Mr. Oluyemi OkupeCFO | -3.99k | 190.52k | Automatic Disposition | 47.70 | 124.66k | -3.10% |
| 2025-07-07 | Mr. Oluyemi OkupeCFO | -6.44k | 268.17k | Derivative Exercise and Sale | 5.01 - 46.67 | 58.08k | - |
| 2025-07-07 | Mr. Oluyemi OkupeCFO | -5.14k | 240.08k | Automatic Disposition | 46.67 | 58.08k | -8.14% |
| 2025-06-30 | Ms. Soleil Teubner BoughtonChief Legal Officer & Corporate Secretary | -2.57k | 129.89k | Automatic Disposition | 50.50 | 160.74k | -1.57% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
